Medtech / Diagnostics
Driving Innovation
Medtech is one of the fastest growing and broadest sectors at Coulter Partners. With 20 years of experience working with medtech companies of all kinds, we have developed a deep understanding of the ever-evolving landscape. The last few years, including the pandemic, have been ultra-challenging for parts of this wide-ranging sector, especially where hospitals are the customer. Our clients include highly innovative devices, life science tools, diagnostics and health tech businesses.
We bring our clients modern thinking and expert leadership to enable them to adapt and accelerate in response to the latest market trends, technological advances and challenges.
The digital revolution has driven connectivity, automation, a complex range of industry and hospital partnerships, the facilitation and growth of at-home treatment, telemedicine, wellness management and other evolutions in access to expertise, diagnosis and treatment. Supply chain challenges have continued, however, and there are considerable pandemic and macro-economic challenges affecting these sectors. We are committed to helping our clients navigate the road bumps and grow opportunities.
Our global access to best-in-class talent means we stay ahead of the curve in meeting our clients’ leadership needs. Some strong themes recently have included finding, assessing and developing talent in technical, development, market access, medical affairs, digital and commercial roles.
For our experts in this sector, please use our searchable Team page.
Related
-
Events
LSX Inv€$tival Showcase
18 November 2024
-
Press Releases
Coulter Partners places new Chair at ArcticZymes Technologies
28 October 2024
-
Company News
Coulter Partners hosts inaugural annual partners meeting
17 October 2024
-
Placement News
Top hires for VC & PE portfolio companies Q3-2024
14 October 2024